ConvaTec Group’s (CTEC) Buy Rating Reaffirmed at Berenberg Bank

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reaffirmed by stock analysts at Berenberg Bank in a report released on Wednesday,London Stock Exchange reports. They currently have a GBX 310 ($4.00) price objective on the stock. Berenberg Bank’s price target would suggest a potential upside of 16.37% from the stock’s previous close.

ConvaTec Group Price Performance

Shares of CTEC traded down GBX 3 ($0.04) during trading hours on Wednesday, hitting GBX 266.40 ($3.43). The stock had a trading volume of 30,865,563 shares, compared to its average volume of 13,549,688. The stock has a market capitalization of £6.77 billion, a price-to-earnings ratio of 44.86, a P/E/G ratio of 0.93 and a beta of 0.64. The company has a debt-to-equity ratio of 85.32, a current ratio of 2.26 and a quick ratio of 0.96. The company’s fifty day moving average is GBX 239.15 and its two-hundred day moving average is GBX 232.91. ConvaTec Group has a 52 week low of GBX 211.80 ($2.73) and a 52 week high of GBX 295.20 ($3.81).

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.